fda compounding semaglutide warning november 2025 and Novo Nordisk Warn of GLP-1 Telehealth Take Down – What's Next? FDA Warns Novo Nordisk on

Self-pay options In March, Novo Nordisk cut the price of all doses of Wegovy by 23% for people paying in cash, dropping it from $650 to $499 per month for uninsured patients or those without coverage

Exercise and Lifestyle Factors Along with food, there are a variety of lifestyle factors that can stimulate GLP-1 production in the body

Once off the medication, old habits like stress snacking or eating out of boredom can creep back in, especially if emotional eating patterns were never fully addressed during treatment

introduce a free-response option for patients to describe the medication usage experience

Most patients begin noticing physical and metabolic changes within the first 4 to 8 weeks

The medication creates caloric deficit through appetite suppression